Compare Open Text Corporation (OTEX) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Open Text Corporation vs Revvity Inc — how do they compare? Open Text Corporation trades at $23.7 (market cap $5.61B), while Revvity Inc trades at $154.18 (market cap $16.98B). The key difference: Revvity Inc is far larger — about 3× Open Text Corporation's market cap, and Open Text Corporation pays the higher dividend (4.82%). Which is the better fit depends on your goals — on Pluang, investors hold Open Text Corporation for 23 Days and Revvity Inc for 12 Days on average.
| OTEX | RVTY | |
|---|---|---|
Market Cap | $5.61B | $16.98B |
Volume | 1,197,475 | 1,456,900 |
Sector | Technology | Health |
52-Week High | $39.69 | $157.36 |
52-Week Low | $20.01 | $82.26 |
Typical Hold Time | 23 Days | 12 Days |
Enterprise Value | $10.63B | $19.30B |
Dividend Yield | 4.82% | 0.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OpenText (OTEX) trades at $23.695, up 2.4% today, with a bearish technical signal despite recent earnings beats. The stock is valued at a P/E of 9.01 and P/S of 1.1, below sector averages, while showing strong profitability with a net margin of 12.26%. Recent news highlights a $1 billion senior secured notes offering and a partnership with Cohere to advance AI capabilities, indicating strategic debt management and growth initiatives.
The outlook is mixed: valuation discounts and cloud growth present opportunities, but high debt and bearish technicals pose risks. Analysts are cautiously optimistic with a $28.30 price target, though execution on AI integration and debt reduction will be critical for sustained upside.
Revvity (RVTY) trades at $154.18, up 0.38% today and near its 52-week high of $158.28. The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for the last three quarters. Recent developments include the launch of a new diabetes screening kit in Europe and the acquisition of Human Cell Design to expand its metabolic disease research tools. Revenue remains stable around $2.9 billion, though net income margin is modest at 8.16%.
The outlook is positive with analyst consensus leaning buy (51.72%) and a price target of $132.13, though the current price exceeds it. Key opportunities include diagnostic growth and AI-driven demand, while risks involve premium valuation (P/E 73.15), margin pressures, and exposure to China market volatility. Earnings on November 3, 2026, will be critical for near-term direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
